Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,359 | $15,803 | $14,237 | $13,164 |
| - Cash | $239 | $298 | $212 | $105 |
| + Debt | $5 | $6 | $6 | $7 |
| Enterprise Value | $15,126 | $15,511 | $14,032 | $13,067 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$15 |
| % Margin | – | – | – | – |
| EBITDA | -$232 | -$566 | -$63 | -$61 |
| % Margin | – | – | – | – |
| Net Income | -$232 | -$566 | -$63 | -$61 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.76 | -0.085 | -0.083 |
| % Growth | 59.2% | -792% | -2.7% | – |
| Operating Cash Flow | -$95 | -$67 | -$61 | -$49 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$95 | -$67 | -$62 | -$49 |